DE69320405D1 - Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon - Google Patents

Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon

Info

Publication number
DE69320405D1
DE69320405D1 DE69320405T DE69320405T DE69320405D1 DE 69320405 D1 DE69320405 D1 DE 69320405D1 DE 69320405 T DE69320405 T DE 69320405T DE 69320405 T DE69320405 T DE 69320405T DE 69320405 D1 DE69320405 D1 DE 69320405D1
Authority
DE
Germany
Prior art keywords
ester
active ingredient
compositions containing
ophthalmic compositions
ingredient vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69320405T
Other languages
English (en)
Other versions
DE69320405T2 (de
Inventor
Yoichi Kawashima
Mitsuaki Kuwano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of DE69320405D1 publication Critical patent/DE69320405D1/de
Application granted granted Critical
Publication of DE69320405T2 publication Critical patent/DE69320405T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69320405T 1992-05-26 1993-05-21 Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon Expired - Fee Related DE69320405T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13319392 1992-05-26

Publications (2)

Publication Number Publication Date
DE69320405D1 true DE69320405D1 (de) 1998-09-24
DE69320405T2 DE69320405T2 (de) 1999-01-14

Family

ID=15098888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69320405T Expired - Fee Related DE69320405T2 (de) 1992-05-26 1993-05-21 Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon

Country Status (11)

Country Link
US (1) US5559157A (de)
EP (1) EP0572190B1 (de)
JP (1) JP2811036B2 (de)
KR (1) KR100260061B1 (de)
CN (1) CN1053807C (de)
AT (1) ATE169815T1 (de)
CA (1) CA2096902A1 (de)
DE (1) DE69320405T2 (de)
DK (1) DK0572190T3 (de)
ES (1) ES2121948T3 (de)
TW (1) TW266154B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5811453A (en) * 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
DE69714081T2 (de) * 1997-04-25 2002-11-14 Schering Plough K K Augentropfen enthaltend ein loratidinmetabolit
US6226118B1 (en) 1997-06-18 2001-05-01 Olympus Optical Co., Ltd. Optical microscope
US6906858B2 (en) 2000-07-17 2005-06-14 Olympus Optical Co., Ltd. Microscope provided with an objective lens focusing apparatus and an objective lens switching apparatus
WO2003097026A1 (fr) * 2002-05-22 2003-11-27 Nihon Pharmaceutical Co., Ltd. Inhibiteur du peristaltisme de muscles lisses
JP4789479B2 (ja) * 2004-02-23 2011-10-12 ロート製薬株式会社 プラノプロフェン含有水性組成物
DE102004045622A1 (de) * 2004-09-17 2006-03-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Konservierungsmittel-Zusammensetzungen
US9993558B2 (en) * 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
CA2644188C (en) * 2006-03-07 2013-11-05 Aquanova Ag Solubilisates of preservatives and procedure for manufacturing them
WO2008002582A2 (en) * 2006-06-27 2008-01-03 Riolan Technologies, Inc. Ultraviolet absorbing ophthalmic compositions
CN101278908B (zh) * 2008-05-18 2010-10-13 程浩文 一种左氧氟沙星滴眼液
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2306684A1 (fr) * 1975-04-11 1976-11-05 Crinex Lab Nouvelle composition a action immunostimulante
JPS60246695A (ja) * 1984-05-22 1985-12-06 松下電器産業株式会社 印刷配線板の製造方法
JPH0737381B2 (ja) * 1987-05-15 1995-04-26 参天製薬株式会社 ビタミンｅ水性製剤
WO1989003689A1 (en) * 1987-10-19 1989-05-05 The Liposome Company, Inc. Tocopherol-based pharmaceutical systems
JPH01106018A (ja) * 1987-10-20 1989-04-24 Asahi Glass Co Ltd 液晶表示素子

Also Published As

Publication number Publication date
CA2096902A1 (en) 1993-11-27
ATE169815T1 (de) 1998-09-15
KR100260061B1 (en) 2000-07-01
EP0572190A1 (de) 1993-12-01
KR940005269A (ko) 1994-03-21
CN1085082A (zh) 1994-04-13
JPH0640910A (ja) 1994-02-15
JP2811036B2 (ja) 1998-10-15
ES2121948T3 (es) 1998-12-16
US5559157A (en) 1996-09-24
CN1053807C (zh) 2000-06-28
TW266154B (de) 1995-12-21
EP0572190B1 (de) 1998-08-19
DE69320405T2 (de) 1999-01-14
DK0572190T3 (da) 1999-02-22

Similar Documents

Publication Publication Date Title
DE69320405T2 (de) Ophthalmische Zusammensetzungen enthaltend als Wirkstoff Vitamin-E oder Ester davon
AU4438489A (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
FI850078A0 (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
FI893701A (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
ES2119919T3 (es) Derivados de dihidrobenzofurano, su preparacion y su utilizacion.
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
ATE102942T1 (de) Antirhinovirale pyridazinamine.
DE69021525T2 (de) Pyrrolaldehydderivate.
BG93515A (bg) Тиазолил-5-карбонамидни производни и средство за борба срещу вредители по растенията
SE8001981L (sv) Kompositioner for behandling av glaukom
DK0447325T5 (da) Ascorbinsyrederivater
DE3168004D1 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee